Search

John D. Pak

Examiner (ID: 5837, Phone: (571)272-0620 , Office: P/1616 )

Most Active Art Unit
1616
Art Unit(s)
2899, 1616, 1209, 1699, 1621
Total Applications
2719
Issued Applications
1510
Pending Applications
255
Abandoned Applications
976

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16809515 [patent_doc_number] => 20210132069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => METHODS OF DETECTING PROGESTERONE RECEPTOR AND OF DETECTING AN EXPRESSION LEVEL [patent_app_type] => utility [patent_app_number] => 17/147151 [patent_app_country] => US [patent_app_date] => 2021-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16690 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17147151 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/147151
METHODS OF DETECTING PROGESTERONE RECEPTOR AND OF DETECTING AN EXPRESSION LEVEL Jan 11, 2021 Pending
Array ( [id] => 17053600 [patent_doc_number] => 20210263034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-26 [patent_title] => DATA PROCESSING SYSTEM FOR IDENTIFYING A THERAPEUTIC AGENT [patent_app_type] => utility [patent_app_number] => 17/144108 [patent_app_country] => US [patent_app_date] => 2021-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 112508 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17144108 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/144108
DATA PROCESSING SYSTEM FOR IDENTIFYING A THERAPEUTIC AGENT Jan 6, 2021 Abandoned
Array ( [id] => 17214895 [patent_doc_number] => 20210348232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-11 [patent_title] => GENETIC POLYMORPHISMS ASSOCIATED WITH CARDIOVASCULAR DISORDERS AND DRUG RESPONSE, METHODS OF DETECTION AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/140716 [patent_app_country] => US [patent_app_date] => 2021-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58914 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17140716 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/140716
GENETIC POLYMORPHISMS ASSOCIATED WITH CARDIOVASCULAR DISORDERS AND DRUG RESPONSE, METHODS OF DETECTION AND USES THEREOF Jan 3, 2021 Abandoned
Array ( [id] => 16948535 [patent_doc_number] => 20210207226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-08 [patent_title] => DNA BARCODING-BASED METHOD FOR RAPID IDENTIFICATION OF LYCIUM CHINENSIS [patent_app_type] => utility [patent_app_number] => 17/136208 [patent_app_country] => US [patent_app_date] => 2020-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6198 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17136208 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/136208
DNA BARCODING-BASED METHOD FOR RAPID IDENTIFICATION OF LYCIUM CHINENSIS Dec 28, 2020 Abandoned
Array ( [id] => 16917677 [patent_doc_number] => 20210190769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => DISTINGUISHING CANCER FROM NEUROLOGICAL RISK USING COPY NUMBER VARIATION [patent_app_type] => utility [patent_app_number] => 17/128446 [patent_app_country] => US [patent_app_date] => 2020-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8390 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17128446 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/128446
DISTINGUISHING CANCER FROM NEUROLOGICAL RISK USING COPY NUMBER VARIATION Dec 20, 2020 Abandoned
Array ( [id] => 18739985 [patent_doc_number] => 20230348955 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-02 [patent_title] => METHODS OF PRODUCING TARGET CAPTURE NUCLEIC ACIDS [patent_app_type] => utility [patent_app_number] => 17/783927 [patent_app_country] => US [patent_app_date] => 2020-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13903 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -49 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17783927 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/783927
METHODS OF PRODUCING TARGET CAPTURE NUCLEIC ACIDS Dec 17, 2020 Pending
Array ( [id] => 16920171 [patent_doc_number] => 20210193263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => DESIGNING PROBES FOR DEPLETING ABUNDANT TRANSCRIPTS [patent_app_type] => utility [patent_app_number] => 17/125378 [patent_app_country] => US [patent_app_date] => 2020-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13867 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17125378 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/125378
DESIGNING PROBES FOR DEPLETING ABUNDANT TRANSCRIPTS Dec 16, 2020 Abandoned
Array ( [id] => 18109930 [patent_doc_number] => 20230002810 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-05 [patent_title] => Method for Carrying Out an Amplification Reaction in a Microfluidic Apparatus [patent_app_type] => utility [patent_app_number] => 17/757132 [patent_app_country] => US [patent_app_date] => 2020-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4866 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17757132 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/757132
Method for Carrying Out an Amplification Reaction in a Microfluidic Apparatus Dec 9, 2020 Pending
Array ( [id] => 18169119 [patent_doc_number] => 20230035730 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-02 [patent_title] => SOLUBLE CD28 LEVELS DURING IMMUNOTHERAPY [patent_app_type] => utility [patent_app_number] => 17/781966 [patent_app_country] => US [patent_app_date] => 2020-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8427 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17781966 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/781966
SOLUBLE CD28 LEVELS DURING IMMUNOTHERAPY Dec 1, 2020 Pending
Array ( [id] => 18825459 [patent_doc_number] => 11840730 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2023-12-12 [patent_title] => Methods and compositions for evaluating genetic markers [patent_app_type] => utility [patent_app_number] => 16/952764 [patent_app_country] => US [patent_app_date] => 2020-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 18 [patent_no_of_words] => 30089 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16952764 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/952764
Methods and compositions for evaluating genetic markers Nov 18, 2020 Issued
Array ( [id] => 17867413 [patent_doc_number] => 20220290149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-15 [patent_title] => METHOD OF DETECTION OF FIBRIN CLOTS [patent_app_type] => utility [patent_app_number] => 17/770241 [patent_app_country] => US [patent_app_date] => 2020-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12903 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17770241 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/770241
METHOD OF DETECTION OF FIBRIN CLOTS Nov 11, 2020 Abandoned
Array ( [id] => 16621900 [patent_doc_number] => 20210040553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-11 [patent_title] => OLIGONUCLEOTIDE FRAGMENT, AND METHOD AS WELL AS APPLICATION OF SELECTIVE AMPLIFICATION OF VARIANT OF TARGET NUCLEIC ACID SEQUENCE USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/083595 [patent_app_country] => US [patent_app_date] => 2020-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9447 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17083595 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/083595
OLIGONUCLEOTIDE FRAGMENT, AND METHOD AS WELL AS APPLICATION OF SELECTIVE AMPLIFICATION OF VARIANT OF TARGET NUCLEIC ACID SEQUENCE USING THE SAME Oct 28, 2020 Abandoned
Array ( [id] => 16778422 [patent_doc_number] => 20210115500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-22 [patent_title] => GENOTYPING EDITED MICROBIAL STRAINS [patent_app_type] => utility [patent_app_number] => 17/072449 [patent_app_country] => US [patent_app_date] => 2020-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40315 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17072449 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/072449
GENOTYPING EDITED MICROBIAL STRAINS Oct 15, 2020 Abandoned
Array ( [id] => 17082475 [patent_doc_number] => 20210277481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-09 [patent_title] => CIRCULATING TUMOR AND TUMOR STEM CELL DETECTION USING GENOMIC SPECIFIC PROBES [patent_app_type] => utility [patent_app_number] => 17/061412 [patent_app_country] => US [patent_app_date] => 2020-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27042 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17061412 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/061412
CIRCULATING TUMOR AND TUMOR STEM CELL DETECTION USING GENOMIC SPECIFIC PROBES Sep 30, 2020 Abandoned
Array ( [id] => 16720482 [patent_doc_number] => 20210087629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-25 [patent_title] => Methods for Treating and Detecting Sepsis in Humans [patent_app_type] => utility [patent_app_number] => 17/038496 [patent_app_country] => US [patent_app_date] => 2020-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19534 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17038496 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/038496
Methods for Treating and Detecting Sepsis in Humans Sep 29, 2020 Abandoned
Array ( [id] => 16728186 [patent_doc_number] => 20210095333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-01 [patent_title] => QUANTIFICATION OF MOLECULES USING NUCLEIC ACID STRAND DISPLACEMENT DETECTION [patent_app_type] => utility [patent_app_number] => 17/039956 [patent_app_country] => US [patent_app_date] => 2020-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5266 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17039956 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/039956
QUANTIFICATION OF MOLECULES USING NUCLEIC ACID STRAND DISPLACEMENT DETECTION Sep 29, 2020 Abandoned
Array ( [id] => 16728204 [patent_doc_number] => 20210095351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-01 [patent_title] => Methods of Preparing Dual Indexed Methyl-Seq Libraries [patent_app_type] => utility [patent_app_number] => 17/036986 [patent_app_country] => US [patent_app_date] => 2020-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5874 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17036986 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/036986
Methods of Preparing Dual Indexed Methyl-Seq Libraries Sep 28, 2020 Pending
Array ( [id] => 17930146 [patent_doc_number] => 20220325271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-13 [patent_title] => DROPLET-BASED SINGLE EXTRACELLULAR VESICLE SEQUENCING [patent_app_type] => utility [patent_app_number] => 17/765145 [patent_app_country] => US [patent_app_date] => 2020-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8678 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17765145 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/765145
DROPLET-BASED SINGLE EXTRACELLULAR VESICLE SEQUENCING Sep 27, 2020 Pending
Array ( [id] => 16541369 [patent_doc_number] => 20200407782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-31 [patent_title] => METHODS OF DETECTING NUCLEIC ACIDS IN INDIVIDUAL CELLS AND OF IDENTIFYING RARE CELLS FROM LARGE HETEROGENEOUS CELL POPULATIONS [patent_app_type] => utility [patent_app_number] => 17/012394 [patent_app_country] => US [patent_app_date] => 2020-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32980 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17012394 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/012394
METHODS OF DETECTING NUCLEIC ACIDS IN INDIVIDUAL CELLS AND OF IDENTIFYING RARE CELLS FROM LARGE HETEROGENEOUS CELL POPULATIONS Sep 3, 2020 Abandoned
Array ( [id] => 17853120 [patent_doc_number] => 20220283162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-08 [patent_title] => MCM5 ELISA FOR THE DETECTION OF RECURRENT BLADDER CANCER [patent_app_type] => utility [patent_app_number] => 17/634579 [patent_app_country] => US [patent_app_date] => 2020-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19434 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17634579 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/634579
MCM5 ELISA FOR THE DETECTION OF RECURRENT BLADDER CANCER Aug 31, 2020 Abandoned
Menu